Teva, Intel to develop wearable technology for Huntington's disease

(Reuters) - Teva Pharmaceutical Industries Ltd said on Thursday it was collaborating with Intel Corp to develop a wearable technology platform to track the progression of disease in patients with Huntington's, a fatal degenerative disorder.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news